Singapore Immunoassay Analyzers and Reagents

2022 Singapore Immunoassay Analyzers and Reagents--Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

This new report from is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years.

The report is available by section, and can be customized to specific information needs and budget. The report provides specimen, test volume and Sales Segment forecasts; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Individual Tests Analyzed in the Report

Clinical Chemistry

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcium, Carbon Dioxide/Bicarbonate, Cardio CRP, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Triglycerides, Troponin, Uric Acid

Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin

Endocrine Function

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Free, T3 Uptake, T4, T4 Free, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH

Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12

Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis

Drugs of Abuse

Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants

Current and Emerging Products

- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Assessment

- Assessment of current and emerging technologies, and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their Sales Segment, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.


I. Introduction

II. Worldwide Market and Technology Overview

A. Major Routine Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin, Total
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cardio CRP
12. Cholesterol
13. Cholinesterase
14. CRP
15. Creatinine
16. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
b. Potassium
d. Sodium
17. Ferritin
18. Fructosamine
19. Gamma-Glutamyl Transpeptidase (GGT)
20. Glucose
21. High Density Lipoprotein (HDL)
22. Homocysteine
23. Iron
24. Lactate Dehydrogenase (LDH)
25. Magnesium
26. Phosphorus
27. Protein
28. Triglycerides
29. Uric Acid
30. Troponin

G. Instrumentation Review: Operating characteristics
and features of high-, medium-, and low-volume/POC analyzers


H. Major In Vitro Diagnostic Technologies
and Their Potential Applications

1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle b.
Chemiluminescence
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

VI. Market Size, Growth and Sales Forecasts by Test

VII. Major Product Development Opportunities

VIII. Design Criteria for Decentralized Testing Products

IX. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

X. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XI. Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujifilm Wako
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
OrthoQuidel
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh

List Of Tables

All Market Segments, Routine
Chemistry Test Volume Forecast by Assay
All Market Segments, Endocrine
Function Test Volume Forecast by Assay
All Market Segments, Tumor Markers and
Special Chemistry Test Volume Forecast by Assay
All Market Segments, Immunoprotein
Test Volume Forecast by Assay
All Market Segments, TDM
Test Volume Forecast by Assay
All Market Segments, Drugs of Abuse
Test Volume Forecast by Assay
Total Clinical Chemistry and Immunoassay
Reagent Market Forecast by Test Category
All Market Segments, Routine Chemistry
Reagent Market Forecast by Assay
All Market Segments, Endocrine Function
Reagent Market Forecast by Assay
All Market Segments, Tumor Markers and
Special Chemistry Reagent Market Forecast by Assay
All Market Segments, Immunoprotein
Reagent Market Forecast by Assay
All Market Segments, TDM
Reagent Market Forecast by Assay
All Market Segments, Drugs of Abuse
Reagent Market Forecast by Assay
Major Companies Developing or
Marketing Albumin Tests
Major Companies Developing or Marketing
Alkaline Phosphatase Tests
Major Companies Developing or
Marketing ALT/SGPT Tests
Major Companies Developing or
Marketing Amylase Tests
Major Companies Developing or
Marketing AST/SGOT Tests
Major Companies Developing or
Marketing Bilirubin Tests
Major Companies Developing or
Marketing Blood Gas Analyzers
Major Companies Developing or
Marketing BUN Tests
Major Companies Developing or
Marketing Calcium Tests
Major Companies Developing or
Marketing Cholesterol Tests
Major Companies Developing or
Marketing Creatinine Tests
Major Companies Developing or
Marketing Electrolyte Tests
Major Companies Developing or
Marketing GGT Tests
Major Companies Developing or
Marketing Glucose Tests
Major Companies Developing or
Marketing HDL Tests
Major Companies Developing or
Marketing Iron Tests
Major Companies Developing or
Marketing LDH Tests
Major Companies Developing or
Marketing Magnesium Tests
Major Companies Developing or
Marketing Phosphorus Tests
Major Companies Developing or
Marketing Protein Tests
Major Companies Developing or
Marketing Triglycerides Tests
Major Companies Developing or
Marketing Uric Acid Tests
Major Companies Developing or
Marketing TDM Tests
Major Companies Developing or
Marketing Digoxin Tests
Major Companies Developing or
Marketing Lithium Tests
Major Companies Developing or
Marketing Phenytoin/Dilantin Tests
Major Companies Developing or
Marketing Theophylline Tests
Major Companies Developing or
Marketing Valproic Acid Tests
Major Companies Developing or
Marketing FSH Tests
Major Companies Developing or
Marketing HCG Tests
Major Companies Developing or
Marketing LH Tests
Major Companies Developing or
Marketing Prolactin Tests
Major Companies Developing or
Marketing T3 Tests
Major Companies Developing or
Marketing T4 Tests
Major Companies Developing or
Marketing TSH Tests
Major Companies Developing or
Marketing AFP Tests
Major Companies Developing or
Marketing CEA Tests
Major Companies Developing or
Marketing Ferritin Tests
Major Companies Developing or
Marketing Occult Blood Tests
Major Companies Developing or Marketing
Prostatic Acid Phosphatase Tests
Major Companies Developing or
Marketing PSA Tests
Major Companies Developing or
Marketing Vitamin B-12/Folate Tests
Major Companies Developing or
Marketing CRP Tests
Major Companies Developing or
Marketing Drugs of Abuse Tests

Singapore Hematology Flow Cytometry Database Analyzers

2024 Singapore Hematology and Flow Cytometry Database: Analyzers and Reagents, Supplier Shares, Test Volume and Sales Forecasts This database from provides the 2023 supplier shares, the 2023-2028 volume and

USD 1450 View Report

Singapore Hematology Flow Cytometry Database Analyzers

2024 Singapore Hematology and Flow Cytometry Database: Analyzers and Reagents, Supplier Shares, Test Volume and Sales Forecasts This database from provides the 2023 supplier shares, the 2023-2028 volume and

USD 1450 View Report

2024 Vietnam Immunoassay Analyzers and Reagents Supplier Shares

2024 Vietnam Immunoassay Analyzers and Reagents--2023 Supplier Shares and Competitive Analysis, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry

USD 2850 View Report

2024 Venezuela Immunoassay Analyzers and Reagents Supplier Shares

2024 Venezuela Immunoassay Analyzers and Reagents--2023 Supplier Shares and Competitive Analysis, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available